Literature DB >> 29614468

Energy expenditure in people with transtibial amputation walking with crossover and energy storing prosthetic feet: A randomized within-subject study.

Cody L McDonald1, Patricia A Kramer2, Sara J Morgan1, Elizabeth G Halsne1, Sarah M Cheever1, Brian J Hafner3.   

Abstract

BACKGROUND: Energy storing feet are unable to reduce the energy required for normal locomotion among people with transtibial amputation. Crossover feet, which incorporate aspects of energy storing and running specific feet, are designed to maximize energy return while providing stability for everyday activities. RESEARCH QUESTION: Do crossover prosthetic feet reduce the energy expenditure of walking across a range of speeds, when compared with energy storing feet among people with transtibial amputation due to non-dysvascular causes?
METHODS: A randomized within-subject study was conducted with a volunteer sample of twenty-seven adults with unilateral transtibial amputation due to non-dysvascular causes. Participants were fit with two prostheses. One had an energy storing foot (Össur Variflex) and the other a crossover foot (Össur Cheetah Xplore). Other components, including sockets, suspension, and interface were standardized. Energy expenditure was measured with a portable respirometer (Cosmed K4b2) while participants walked on a treadmill at self-selected slow, comfortable, and fast speeds with each prosthesis. Gross oxygen consumption rates (VO2 ml/min) were compared between foot conditions. Energy storing feet were used as the baseline condition because they are used by most people with a lower limb prosthesis. Analyses were performed to identify people who may benefit from transition to crossover feet.
RESULTS: On average, participants had lower oxygen consumption in the crossover foot condition compared to the energy storing foot condition at each self-selected walking speed, but this difference was not statistically significant. Participants with farther six-minute walk test distances, higher daily step counts, and higher Medicare Functional Classification Levels at baseline were more likely to use less energy in the crossover foot. SIGNIFICANCE: Crossover feet may be most beneficial for people with higher activity levels and physical fitness. Further research is needed to examine the effect of crossover feet on energy expenditure during high-level activities.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amputee; Artificial limb; Energetics; Walking

Mesh:

Year:  2018        PMID: 29614468     DOI: 10.1016/j.gaitpost.2018.03.040

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  5 in total

1.  Mobility analysis of AmpuTees (MAAT 5): Impact of five common prosthetic ankle-foot categories for individuals with diabetic/dysvascular amputation.

Authors:  Shane R Wurdeman; Phillip M Stevens; James H Campbell
Journal:  J Rehabil Assist Technol Eng       Date:  2019-02-13

2.  Understanding LSTM Network Behaviour of IMU-Based Locomotion Mode Recognition for Applications in Prostheses and Wearables.

Authors:  Freddie Sherratt; Andrew Plummer; Pejman Iravani
Journal:  Sensors (Basel)       Date:  2021-02-10       Impact factor: 3.576

3.  High-Level Mobility of Trans-Tibial Prosthesis Users Wearing Commercial and sPace Energy-Storing Prosthetic Feet.

Authors:  Thanyaporn Rakbangboon; Gary Guerra; Saloottra Kla-Arsa; Uthumporn Padungjaroen; Pairat Tangpornprasert; Chanyaphan Virulsri; Kazuhiko Sasaki
Journal:  Int J Environ Res Public Health       Date:  2022-10-02       Impact factor: 4.614

4.  Quantifying Step Count and Oxygen Consumption with Portable Technology during the 2-Min Walk Test in People with Lower Limb Amputation.

Authors:  John D Smith; Gary Guerra
Journal:  Sensors (Basel)       Date:  2021-03-16       Impact factor: 3.576

Review 5.  Reported Outcome Measures in Studies of Real-World Ambulation in People with a Lower Limb Amputation: A Scoping Review.

Authors:  Mirjam Mellema; Terje Gjøvaag
Journal:  Sensors (Basel)       Date:  2022-03-14       Impact factor: 3.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.